BR112012009452A2 - derivado de 5-hidroxipirimidino-4-carboxamida - Google Patents
derivado de 5-hidroxipirimidino-4-carboxamidaInfo
- Publication number
- BR112012009452A2 BR112012009452A2 BR112012009452A BR112012009452A BR112012009452A2 BR 112012009452 A2 BR112012009452 A2 BR 112012009452A2 BR 112012009452 A BR112012009452 A BR 112012009452A BR 112012009452 A BR112012009452 A BR 112012009452A BR 112012009452 A2 BR112012009452 A2 BR 112012009452A2
- Authority
- BR
- Brazil
- Prior art keywords
- group
- ring
- optionally substituted
- monocyclic
- hydroxypyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
derivado de 5-hidroxipirimidino-4-carboxamida. é divulgado um composto que pode acentuar a produção de eritropoietina. especificamente, é divulgado um composto representado pela fórmula (1) em que, r^ 1^ representa um grupo representado pela fórmula (1a) (em que, r^ 4^ e r^ 5 ^ independentemente representam h, um átomo de halogênio ou um grupo alquila; r^ 6^ representa h, um átomo de halogênio, um grupo alquila ou semelhantes; r^ 7^ representa um grupo hidroxiaquila opcionalmente substituído, um grupo hidróxi-halogenoalquila opcionalmente substituído, um grupo alcoxialquila opcionalmente substituído ou semelhantes; o grupo de substituintes <244> inclui um grupo oxo, um grupo hidróxi, um grupo amino e semelhantes; o anel q^ 1^ representa um grupo de heteroanel monocíclico; o anel q^ 2^ representa ym grupo de anel hidrocarboneto monocíclico ou um grupo de heteroanel monocíclico; o anel q^ 3^ representa um grupo de anel hidrocarboneto monocíclico ou um grupo de heteroanel monocíclico; e x representa uma ligação única, um grupo metileno, um grupo etileno ou semelhantes; r^ 2^ representa um grupo alquila ou um grupo metilsulfanila; e r^ 3^ representa h ou um grupo metila ou semelhantes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009242884 | 2009-10-21 | ||
| PCT/JP2010/068476 WO2011049126A1 (ja) | 2009-10-21 | 2010-10-20 | ５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012009452A2 true BR112012009452A2 (pt) | 2016-04-26 |
Family
ID=43900350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012009452A BR112012009452A2 (pt) | 2009-10-21 | 2010-10-20 | derivado de 5-hidroxipirimidino-4-carboxamida |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8785462B2 (pt) |
| EP (1) | EP2492266B1 (pt) |
| JP (1) | JP5718236B2 (pt) |
| KR (1) | KR101665749B1 (pt) |
| CN (1) | CN102712619B (pt) |
| AU (1) | AU2010308942C1 (pt) |
| BR (1) | BR112012009452A2 (pt) |
| CA (1) | CA2780533C (pt) |
| CO (1) | CO6460726A2 (pt) |
| CY (1) | CY1116974T1 (pt) |
| DK (1) | DK2492266T3 (pt) |
| ES (1) | ES2549503T3 (pt) |
| HK (1) | HK1174621A1 (pt) |
| HR (1) | HRP20151110T1 (pt) |
| HU (1) | HUE026128T2 (pt) |
| IL (1) | IL219243A (pt) |
| MX (1) | MX2012004714A (pt) |
| MY (1) | MY163022A (pt) |
| NZ (1) | NZ600017A (pt) |
| PL (1) | PL2492266T3 (pt) |
| PT (1) | PT2492266E (pt) |
| RS (1) | RS54323B1 (pt) |
| RU (1) | RU2550693C2 (pt) |
| SI (1) | SI2492266T1 (pt) |
| SM (1) | SMT201500268B (pt) |
| TW (2) | TWI469975B (pt) |
| WO (2) | WO2011049127A1 (pt) |
| ZA (1) | ZA201202899B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011049127A1 (ja) | 2009-10-21 | 2011-04-28 | 第一三共株式会社 | 炭化水素環基を有する５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
| JP6100755B2 (ja) * | 2012-03-30 | 2017-03-22 | 第一三共株式会社 | （２−ヘテロアリールアミノ）コハク酸誘導体 |
| WO2013147214A1 (ja) * | 2012-03-30 | 2013-10-03 | 第一三共株式会社 | ５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
| WO2014065382A1 (ja) * | 2012-10-26 | 2014-05-01 | 旭硝子株式会社 | ジフルオロエステル化合物の製造方法 |
| WO2016054804A1 (en) * | 2014-10-10 | 2016-04-14 | Merck Sharp & Dohme Corp. | Substituted pyrimidines as inhibitors of hif prolyl hydroxylase |
| EP3391887A4 (en) * | 2015-12-16 | 2019-08-21 | Daiichi Sankyo Company, Limited | WOUND TREATMENT AGENT |
| KR20180128461A (ko) | 2016-04-08 | 2018-12-03 | 각고호우징 게이오기주크 | 젖산산증의 예방 또는 치료를 위한 의약 |
| WO2019099294A1 (en) * | 2017-11-14 | 2019-05-23 | Merck Sharp & Dohme Corp. | Novel substituted biaryl compounds as indoleamine 2,3-dioxygenase (ido) inhibitors |
| TW201936598A (zh) * | 2018-02-19 | 2019-09-16 | 日商第一三共股份有限公司 | 炎症性腸病治療劑 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003049686A2 (en) | 2001-12-06 | 2003-06-19 | Fibrogen, Inc. | Stabilization of hypoxia inducible factor (hif) alpha |
| CN102718708A (zh) * | 2003-06-06 | 2012-10-10 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
| US7501538B2 (en) | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
| WO2006133391A2 (en) * | 2005-06-06 | 2006-12-14 | Fibrogen, Inc. | Improved treatment for anemia using a hif-alpha stabilising agent |
| WO2007038571A2 (en) | 2005-09-26 | 2007-04-05 | Smithkline Beecham Corporation | Prolyl hydroxylase antagonists |
| WO2007136990A2 (en) | 2006-05-16 | 2007-11-29 | Smithkline Beecham Corporation | Prolyl hydroxylase inhibitors |
| JO2934B1 (en) * | 2006-06-23 | 2015-09-15 | سميث كلاين بيتشام كوربوريشن | Prolyl hydroxylase inhibitors |
| PL3026044T3 (pl) | 2006-06-26 | 2019-04-30 | Akebia Therapeutics Inc | Inhibitory prolilo-hydroksylazy i sposoby ich użycia |
| CL2008000066A1 (es) * | 2007-01-12 | 2008-08-01 | Smithkline Beecham Corp | Compuestos derivados de (5-hidroxi-3-oxo-2,3-dihidropiridazina-4-carbonil)glicina, inhibidores de hif prolil hidroxilasas; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anem |
| CL2008000065A1 (es) | 2007-01-12 | 2008-09-22 | Smithkline Beecham Corp | Compuestos derivados de glicina n-sustituida, inhibidores de hif prolil hidroxilasas; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la anemia. |
| CA2718528C (en) * | 2008-03-18 | 2016-10-25 | Merck Sharp & Dohme Corp. | Substituted 4-hydroxypyrimidine-5-carboxamides |
| EP2284159A4 (en) * | 2008-04-22 | 2012-06-13 | Daiichi Sankyo Co Ltd | 5-hydroxypyrimidine-4-carboxamide compound |
| WO2011049127A1 (ja) | 2009-10-21 | 2011-04-28 | 第一三共株式会社 | 炭化水素環基を有する５－ヒドロキシピリミジン－４－カルボキサミド誘導体 |
| JP2011105708A (ja) * | 2009-10-21 | 2011-06-02 | Daiichi Sankyo Co Ltd | ５−ヒドロキシピリミジン−４−カルボキサミド化合物を含有する医薬組成物 |
| TW201141839A (en) | 2010-04-19 | 2011-12-01 | Daiichi Sankyo Co Ltd | Substituted 5-hydroxypyrimidine-4-carboxamide compounds |
-
2010
- 2010-10-20 WO PCT/JP2010/068477 patent/WO2011049127A1/ja active Application Filing
- 2010-10-20 US US13/503,340 patent/US8785462B2/en active Active
- 2010-10-20 KR KR1020127010014A patent/KR101665749B1/ko active IP Right Grant
- 2010-10-20 SI SI201031047T patent/SI2492266T1/sl unknown
- 2010-10-20 EP EP10824975.6A patent/EP2492266B1/en active Active
- 2010-10-20 CN CN201080058211.0A patent/CN102712619B/zh active Active
- 2010-10-20 ES ES10824975.6T patent/ES2549503T3/es active Active
- 2010-10-20 AU AU2010308942A patent/AU2010308942C1/en active Active
- 2010-10-20 NZ NZ600017A patent/NZ600017A/en unknown
- 2010-10-20 WO PCT/JP2010/068476 patent/WO2011049126A1/ja active Application Filing
- 2010-10-20 TW TW99135723A patent/TWI469975B/zh not_active IP Right Cessation
- 2010-10-20 PL PL10824975T patent/PL2492266T3/pl unknown
- 2010-10-20 MX MX2012004714A patent/MX2012004714A/es active IP Right Grant
- 2010-10-20 RS RS20150670A patent/RS54323B1/en unknown
- 2010-10-20 TW TW099135716A patent/TW201124397A/zh unknown
- 2010-10-20 JP JP2011537279A patent/JP5718236B2/ja active Active
- 2010-10-20 BR BR112012009452A patent/BR112012009452A2/pt not_active Application Discontinuation
- 2010-10-20 HU HUE10824975A patent/HUE026128T2/en unknown
- 2010-10-20 PT PT108249756T patent/PT2492266E/pt unknown
- 2010-10-20 DK DK10824975.6T patent/DK2492266T3/en active
- 2010-10-20 CA CA2780533A patent/CA2780533C/en active Active
- 2010-10-20 RU RU2012120749/04A patent/RU2550693C2/ru active
- 2010-10-20 MY MYPI2012001770A patent/MY163022A/en unknown
-
2012
- 2012-04-17 IL IL219243A patent/IL219243A/en active IP Right Grant
- 2012-04-19 ZA ZA2012/02899A patent/ZA201202899B/en unknown
- 2012-05-18 CO CO12082335A patent/CO6460726A2/es unknown
-
2013
- 2013-02-04 HK HK13101564.9A patent/HK1174621A1/xx unknown
-
2015
- 2015-10-21 HR HRP20151110TT patent/HRP20151110T1/hr unknown
- 2015-10-28 SM SM201500268T patent/SMT201500268B/it unknown
- 2015-11-24 CY CY20151101058T patent/CY1116974T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012009452A2 (pt) | derivado de 5-hidroxipirimidino-4-carboxamida | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| CY1118435T1 (el) | Παραγωγο μορφολινο νουκλεϊνικου οξεος | |
| CY1110893T1 (el) | Διαδικασιες και ενδιαμεσες ενωσεις για την παρασκευη ενος μακροκυκλικου αναστολεα πρωτεασης του hcv | |
| RS53705B1 (en) | DI-SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS | |
| BR112013002182A2 (pt) | derivados de quinolina e inibidores de melk contendo os mesmos | |
| CY1120477T1 (el) | Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων | |
| EA201591503A1 (ru) | Производные нафтиридина, полезные в качестве антагонистов альфа-v-бета-6 интегрина | |
| RS54730B1 (sr) | Inhibitori beta sekretaze | |
| EA201070246A1 (ru) | Циклические аминные соединения | |
| HRP20130851T1 (hr) | Adicijske soli amina koji sadrže hidroksilne i/ili karboksilne grupe s derivatima aminonikotinske kiseline kao dhodh inhibitorima | |
| BR112013018732A2 (pt) | novos derivados de amida de aril-benzocicloalquila | |
| MA38583B1 (fr) | Dérivés de dolastatine 10 et d'auristatines | |
| CY1121626T1 (el) | Νεο παραγωγο υδροξαμικου οξεος ή αλας αυτου | |
| CO2018010787A2 (es) | Compuesto de griseofulvina | |
| DK2197860T3 (da) | Nye forbindelser som adenosin-A1-receptorantagonister | |
| AU2018316542A1 (en) | Indole derivatives as histone demethylase inhibitors | |
| MX2017005423A (es) | Inhibidores de histona desacetilasa y sus usos en terapia. | |
| TW201129550A (en) | Method for producing diepoxy compound | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
| ME01144B (me) | 3-aminociklopentankarboksamidi kao modulatori hemokin receptora | |
| BR112012020703A2 (pt) | composição para o controle de pragas | |
| EP2612848A4 (en) | CYCLIC AMIDE DERIVATIVE | |
| BR112013005823B8 (pt) | Compostos heterocíclicos para o tratamento ou prevenção de distúrbios causados pela neurotransmissão reduzida de serotonina, norefnefrina ou dopamina | |
| BR112015028871A2 (pt) | novos compostos de 3,4-dihidro-2h-isoquinolina-1-ona e 2,3-dihidro-isoindol-1-ona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |